Vaccine for preventing African swine fever comprising antigen protein derived from African swine fever virus

The present invention relates to a recombinant vector comprising a base sequence of African swine fever virus antigen protein lectin (Lectin), CD2v, p72, p54, p30, p15, p35, E199L and/or F317L, a transgenic organism transformed from the recombinant vector, and a recombinant vector comprising a base...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KANG HYANG JU, SOHN EUN JU, CHOI BO-HWA
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	AGRICULTURE ANIMAL HUSBANDRY BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FISHING FODDER FOODS OR FOODSTUFFS FORESTRY HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NEW PLANTS OR PROCESSES FOR OBTAINING THEM ORGANIC CHEMISTRY PEPTIDES PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES TRAPPING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a recombinant vector comprising a base sequence of African swine fever virus antigen protein lectin (Lectin), CD2v, p72, p54, p30, p15, p35, E199L and/or F317L, a transgenic organism transformed from the recombinant vector, and a recombinant vector comprising a base sequence of African swine fever virus lectin, CD2v, p72, p54, p30, p15, p35, E199L and/or F317L isolated from the transgenic organism. A vaccine composition for preventing African swine fever, which comprises, as an active ingredient, E199L and/or F317L antigen proteins. 本发明涉及包含非洲猪瘟病毒抗原蛋白凝集素(Lectin)、CD2v、p72、p54、p30、p15、p35、E199L和/或F317L的碱基序列的重组载体、由上述重组载体转化的转基因生物体、以及包含从上述转基因生物体分离的非洲猪瘟病毒的凝集素、CD2v、p72、p54、p30、p15、p35、E199L和/或F317L抗原蛋白作为有效成分的用于预防非洲猪瘟的疫苗组合物等。